Anthony Scott Praill - Chief Financial Officer at Kintara Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
KTRA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Anthony Scott Praill since 11/8/2023

Holdings reported by Anthony Scott Praill for Kintara Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 277K $188K $0.68 Aug 1, 2022 Direct
Option (right to buy) 720K Aug 1, 2022 Direct Common Stock

Transactions reported by Anthony Scott Praill for Kintara Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.